This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
HIF-dependent induction of alveolar miR-147 dampens SARS-CoV-2 immune evasion (preprint)
researchsquare; 2022.
Preprint
in English
| PREPRINT-RESEARCHSQUARE | ID: ppzbmed-10.21203.rs.3.rs-2319034.v1
ABSTRACT
Acute respiratory distress syndrome (ARDS) causes significant morbidity and mortality during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections1,2. Nevertheless, most patients with coronavirus disease 2019 (COVID-19) recover seamlessly without developing ARDS3, suggesting the existence of endogenous pathways to protect the lungs. Since many microRNAs (miRNAs) serve important roles in endogenous regulatory pathways, we pursued functional roles of miRNAs in COVID-19-ARDS. A screen of miRNAs in human alveolar epithelia or mice infected with SARS-CoV-2 identified miR-147 as a lead candidate. Transcriptional analysis implicated hypoxia-inducible factor 1A (HIF1A) in miR-147 induction during alveolar injury or SARS-CoV-2 infection. Functionally, mice with alveolar epithelial deletion of miR-147 showed increased lung injury in response to SARS-CoV-2 infection. mRNA sequencing and subsequent in silico miR-147-target analysis revealed reduced antiviral responses and identified SARS-CoV-2 ORF8 as a direct miR-147 target. Moreover, mice infected with SARS-CoV-2 and treated with miR-147 packaged in DOPC nanoliposomes showed significant protection with enhanced antiviral responses and improved survival. Finally, proof-of-principle studies in patients with COVID-19 highlighted this pathway in human SARS-CoV-2-associated ARDS. Together, our findings identify a previously unrecognized role of miR-147 in lung protection during viral pneumonia by attenuating immune evasion of SARS-CoV-2.
Full text:
Available
Collection:
Preprints
Database:
PREPRINT-RESEARCHSQUARE
Main subject:
Respiratory Distress Syndrome
/
Coronavirus Infections
/
Adenocarcinoma, Bronchiolo-Alveolar
/
COVID-19
/
Lung Diseases
/
Hypoxia
Language:
English
Year:
2022
Document Type:
Preprint
Similar
MEDLINE
...
LILACS
LIS